| This week's sponsor is McKesson Life Sciences. | | | |
Today's Rundown Janssen plunks down $100M for MeiraGTx’s retinal disease gene therapy pipeline Calico brings on Amgen’s translational R&D head to lead early drug development Alexion bags option on Caelum to boost hematology franchise First phase 3 data back Scynexis' new-class antifungal Sylentis' dry eye drug misses primary goals in phase 3 Aduro cuts 37% of employees as it refocuses on cancer pipeline Featured Story | | | Thursday, January 31, 2019 Johnson & Johnson’s Janssen is ramping up its gene therapy work, forking over $100 million upfront to develop MeiraGTx’s clinical-stage gene therapies for retinal diseases. It will have the worldwide rights to market treatments for achromatopsia X-linked retinitis pigmentosa as well as the option to license additional programs in inherited retinal disease. |
|
|
Top Stories Thursday, January 31, 2019 Amgen’s head of translational medicine, Aarif Khakoo, M.D., is making the jump to Calico Life Sciences to head up drug development at Alphabet’s aging-focused life sciences venture. Thursday, January 31, 2019 Alexion has gained an option to buy Caelum Biosciences for its light chain amyloidosis candidate. The deal sees Alexion take an equity stake in the Fortress Biotech subsidiary and commit to a package that could top $500 million. Thursday, January 31, 2019 The first data readout from a phase 3 trial of Scynexis’ ibrexafungerp has come in, and at first glance looks very positive for the first-in-class antifungal. Thursday, January 31, 2019 A phase 3 trial of Sylentis’ dry eye disease candidate tivanisiran has missed its primary endpoints. The PharmaMar subsidiary failed to link the siRNA eye drops to improved scores on scales of ocular pain and corneal staining compared to artificial tears. Thursday, January 31, 2019 Aduro Biotech has hit the reset button, laying off about 37% of its workforce to throw all of its resources behind a handful of lead programs: assets that target the STING and APRIL pathways for the treatment of cancer. | This week's sponsor is ExL Events. | | | |
Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: Veradigm Clinical trials take too long and cost too much—here's what needs to change. Sponsored by: AlphaSense It’s never been more challenging to stay on top of competitive factors impacting your industry. Discover how AI can help competitive teams achieve more proactive market intelligence. Sponsored by: Reprints Desk, Inc. Go from Search to Full-Text Scientific Papers in a Single Click! Sponsored by: Blue Latitude Health This white paper consists of original data and expert interviews. Download it today for exclusive tools, tips and analysis on achieving launch excellence in challenging pharma markets. Sponsored by: Outer Edge Technology With FDA approval imminent, start-up Life Sciences company partners with an industry focused MSP to design and manage its regulated cloud-based infrastructure to speed time to market. Sponsored by: DeciBio Consulting With the liquid biopsy market maturing and >80 companies still competing with liquid biopsy offerings, it is crucial for investors to be able to cut through the noise and identify the winners. Presented by: Veeva Share your thoughts on the life sciences industry's progress in improving study execution. Presented by: Aprecia Get ahead of looming challenges in the market that include both generic products and new branded drugs. Sponsored by: Oracle Health Sciences New infographic shows trends in clinical development and the impact on randomization and trial supply management technology (RTSM). Sponsored by: Veeva Reduce the effort to create submissions and track registrations with a move to unified RIM. Watch the on-demand webinar. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. BIO CEO & Investor Conference February 11-12, 2019 | New York Marriott Marquis Asia-Pacific Compliance Training for Life Sciences Professionals March 4-7, 2019 | Singapore 2019 Bridging Clinical Research & Clinical Health Care Collaborative March 4–5, 2019 | National Academy of Sciences | Washington, D.C. BIO Asia International Conference March 5-6, 2019 | Grand Hyatt Tokyo | Tokyo, Japan Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register and start preparing Today! | 